Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duane A Mitchell

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Neuro-Oncology|June 28, 2017
CD70, a novel target of CAR T-cell therapy for gliomasLinchun Jin, Haitao Ge, Yu Long, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
mRNA challenge predicts brain cancer immunogenicity and response to checkpoint inhibitorsPaul Castillo, Elizabeth Ogando-Rivas, Hilary Geffrard, et al.
Nature Cancer|June 12, 2025
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trialEric M Thompson, David M Ashley, Katayoun Ayasoufi, et al.
Cancer Research|November 3, 2017
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in GlioblastomaElizabeth A Reap, Carter M Suryadevara, Kristen A Batich, et al.
Nature Biomedical Engineering|July 18, 2025
Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreadingSadeem Qdaisat, Brandon Wummer, Brian D Stover, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor responseHaipeng Tao, Dongjiang Chen, Changlin Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
mRNA aggregates harness danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Cancer Control : Journal of the Moffitt Cancer Center|September 13, 2023
Florida-California Cancer Research, Education and Engagement (CaRE<sup>2</sup>) Health Equity Center: Structure, Innovations, and Initial OutcomesR Renee Reams, Folakemi T Odedina, John D Carpten, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Neuro-Oncology|June 28, 2017
CD70, a novel target of CAR T-cell therapy for gliomasLinchun Jin, Haitao Ge, Yu Long, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
mRNA challenge predicts brain cancer immunogenicity and response to checkpoint inhibitorsPaul Castillo, Elizabeth Ogando-Rivas, Hilary Geffrard, et al.
Nature Cancer|June 12, 2025
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trialEric M Thompson, David M Ashley, Katayoun Ayasoufi, et al.
Cancer Research|November 3, 2017
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in GlioblastomaElizabeth A Reap, Carter M Suryadevara, Kristen A Batich, et al.
Nature Biomedical Engineering|July 18, 2025
Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreadingSadeem Qdaisat, Brandon Wummer, Brian D Stover, et al.
The Journal of Clinical Investigation|July 1, 2025
Targeting immune checkpoint LAIR1 with antibody blockade or 3-in-1 CAR T cells enhances antitumor responseHaipeng Tao, Dongjiang Chen, Changlin Yang, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
mRNA aggregates harness danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Cell|May 2, 2024
RNA aggregates harness the danger response for potent cancer immunotherapyHector R Mendez-Gomez, Anna DeVries, Paul Castillo, et al.
Cancer Control : Journal of the Moffitt Cancer Center|September 13, 2023
Florida-California Cancer Research, Education and Engagement (CaRE<sup>2</sup>) Health Equity Center: Structure, Innovations, and Initial OutcomesR Renee Reams, Folakemi T Odedina, John D Carpten, et al.
Pageof 13